This relevance of perturbed KRAS activity in human breast cancer, plus the efficiency, rapidity, and reproducibility of obtaining invasive ductal carcinomas from KRASG12D-transduced primary human mammary cells prompted us to use this latter genetic model to investigate the role of YAP activity in the initiation of human breast cancers. The gene discussed is KRAS; the disease is breast cancer.